Projects

Innovative diagnostics to improve screening for gynecological cancer

The project partners, CC Diagnostics, Molgen, UMCG and IQ Products, together have formed a consortium to improve the screening for gynecological cancer.

Currently, cervical cancer screening is inefficient and women-unfriendly. Every year, one million European women receive an incorrect diagnosis, meaning that expensive follow-up tests (such as colposcopy and biopsies) are unnecessarily performed in hospitals. The current test is experienced as unpleasant by women, which is why between 40-59% of the invited women do not participate in the population screening.

Innovative processes to improve reproducibility in shotgun proteomics

The project partners, Quantall BV, University of Groningen, University Medical Centre of Groningen (UMCG) and IQ Products, together have formed a consortium to improve shotgun proteomics in clinical settings and develop of new usable diagnostic tools.

Recent developments in shotgun proteomics have taken a flight with respect to the identification of more proteins within analysis of one sample, unlocking access to the individual proteome of patients. This opens the door to discover new not yet known biomarkers that play a role in the disease process, which can lead to the development of new therapies and diagnostics.